We found that Tet2 levels were higher in the normal (i.e., “top”) β cells that we showed succumbed to immune killing during the progression of the autoimmune disease when compared to the hypogranular (i.e., “bottom”) cells that survived cytokine and immune cell-mediated killing (Supplementary Fig. 4). The gene discussed is TET2; the disease is autoimmune disease.